Viewing nowNebotron Tablet (Nebivolol Hydrochloride)
Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

MFDS item code 201104063 · Notified 2011.06.30 · Insurance code 653402480
Treatment of essential hypertension; adjunctive treatment of chronic stable heart failure in patients aged 70 years or older
This medication is used as an adjunct to the standard treatment for essential hypertension and mild to moderate chronic stable heart failure, particularly in patients aged 70 years and older. It effectively controls hypertension, reducing the risk of cardiovascular diseases, and helps alleviate symptoms of heart failure. Therefore, this medication is used for the treatment of hypertension and chronic heart failure in the elderly.
1. Essential hypertension Adults: Administer 5mg of nebivolol orally once daily at the same time each day. The blood pressure-lowering effect usually appears after 1~2 weeks of treatment, although it may appear after 4 weeks in some cases. May be taken with food. Patients with renal impairment: The initial dose is 2.5mg of nebivolol orally once daily. If necessary, the daily dose may be increased to 5mg. Older adults: The initial dose for older adults aged 65 years and older is 2.5mg of nebivolol once daily. If necessary, the daily dose may be increased to 5mg. Since clinical experience in patients aged 75 years and older is insufficient, administer with careful monitoring. 2. Chronic heart failure Older patients aged 70 years and older: This medicine should be administered to patients with chronic stable heart failure who have had no history of acute heart failure in the past 6 weeks. Doses of cardiovascular medicines such as diuretics, digoxin, ACE inhibitors, and angiotensin II receptor blockers should have been stabilized by 2 weeks before starting this medicine. Considering the patient's condition, the dose should be gradually increased at intervals of 1~2 weeks until the optimal dose for each patient is reached. Start treatment with 1.25mg of nebivolol once daily and, if necessary, the dose may be increased to 2.5mg once daily, 5mg once daily, and up to 10mg once daily. The maximum daily dose is 10mg. May be taken with food. Patients with renal impairment: Since titration to the maximum tolerated dose is adjusted for each patient, no dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment (serum creatinine≥250μmol/L), as there is no experience with use in these patients.
This medication should not be used in patients with certain diseases. For example, it should not be administered to patients with allergies to this medication or those with bronchial asthma, serious heart issues, or severely impaired liver or kidney function. Pregnant or breastfeeding women are also advised not to use this medication. Patients with hereditary lactose intolerance should exercise caution. Patients with uncontrolled chronic lung disease or heart failure, diabetes, and the elderly should use this medication with particular care. This medication may affect blood pressure and heart rate, thus close monitoring by a physician is necessary for these patients. Various side effects may occur when using this medication. Such as skin rashes, dizziness, headaches, dyspepsia, shortness of breath, fatigue, etc., and in severe cases, heart function deterioration or vascular problems may arise. If undergoing surgery, the use of this medication may need to be discontinued beforehand, and sudden discontinuation can worsen heart problems, so it should be gradually tapered off. This medication can interact with other drugs, so caution is needed when taken alongside calcium channel blockers, antiarrhythmics, central nervous system agents, diabetes medications, etc. Especially, when used with certain drugs, the risk of reduced heart rate or hypotension may increase. In pregnant or breastfeeding cases, side effects may occur in the fetus or newborn, so it is safer not to take this medication. It is not recommended for children under 18 years old as safety and efficacy have not been established. In the elderly, treatment should start at a low dose and be increased gradually with close monitoring of the condition. If an overdose occurs, symptoms such as severe bradycardia, hypotension, or difficulty breathing may manifest; immediate medical treatment should be sought. Treatment may include gastric lavage, discontinuation of the medication, and the use of drugs like atropine.
Rash, vision damage, bradycardia, AV block, AV conduction delay, hypotension, heart failure, intermittent claudication, headache, dizziness, paresthesia, depression, nightmares, syncope, diarrhea, constipation, nausea, dyspepsia, bloating, vomiting, dyspnea, bronchospasm, pruritus, erythematous rash, exacerbation of psoriasis, edema, fatigue, erectile dysfunction, vascular angioedema, hallucinations, psychosis, confusion, cyanosis of limbs, dry eyes, practolol-type conjunctival skin toxicity, Raynaud's phenomenon, orthostatic hypotension, drug intolerance, first-degree AV block, lower limb edema, dizziness, headache, constipation, edema, nausea, chest pain, diarrhea, insomnia, palpitations, dyspepsia, abdominal pain, bradycardia, vomiting, increased urinary frequency, elevated blood glucose, neck/shoulder pain, paresthesia, gastritis, chest pain, fatigue, asthenia, lack of efficacy, weight loss, dyspnea, cough, cold, dry cough, reduced appetite, anxiety, back pain, increased serum creatinine, tinnitus, vertigo, tremor, neuromuscular disorder, gastroesophageal reflux, irritable bowel syndrome, thirst, gastric ulcer, gastrointestinal disorders, systemic weakness, facial edema, generalized edema, upper respiratory tract infection, rhinitis, sore throat, runny nose, agitation, depression, drowsiness, arthralgia, flank pain, neck stiffness, back pain, increased BUN, bladder discomfort, cystitis, urinary stones, hematuria, diabetes, urticaria, tinea, sweating, tinea corporis, hypotension, hypertension, cerebrovascular disease, peripheral vascular disease, flushing, epistaxis, increased ALT, increased AST, viral infection, thyroiditis, chronic myeloid leukemia
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is best to store it at room temperature, between 1 to 30 degrees Celsius.
White round tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowNebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Chodang Pharmaceutical Co., Ltd.

Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Aju Pharmaceuticals Co., Ltd.

Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Ellison Pharmaceutical Co., Ltd.

Nebivolol Hydrochloride 2.725mg
Tablet · Prescription medication
Erison Pharm Co., Ltd.

Nebivolol Hydrochloride 1.3625mg
Tablet · Prescription medication
Ellison Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.